EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the ‘adjusted dose score’

Yusaku Miyata, Etsuyo Ogo, Kenta Murotani, Naotake Tsuda, Gen Suzuki, Chiyoko Tsuji, Ryosuke Akeda, Koichiro Muraki, Chikayuki Hattori, Toshi Abe

Journal of Radiation Research · 2024

DOI: 10.1093/jrr/rrae031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, 2024. Verfasst von Yusaku Miyata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan. Hauptthemen laut MEDLINE: Hyaluronic Acid, Brachytherapy, Uterine Cervical Neoplasms, Radiotherapy Dosage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyaluronate gel injection (HGI) in the rectovaginal septum and vesicovaginal septum is effective in the setting of high-dose-rate image-guided adaptive brachytherapy (IGABT) for cervical cancer. We aimed to retrospectively investigate optimal conditions for HGI to achieve optimal dose distribution with a minimum number of HGI. We classified 50 IGABT plans of 13 patients with cervical cancer who received IGABT both with and without HGI in the rectovaginal septum and vesicovaginal septum into the following two groups: plan with (number of plans = 32) and plan without (number of plans = 18) HGI. The irradiation dose parameters of high-risk clinical target volume (CTVHR) and organs at risk per fraction were compared between these groups. We also developed the adjusted dose score (ADS), reflecting the overall irradiation dose status for four organs at risk and CTVHR in one IGABT plan and investigated its utility in determining the application of HGI. HGI reduced the maximum dose to the most exposed 2.0 cm3 (D2.0 cm3) of the bladder while increasing the minimum dose covering 90% of CTVHR and the percentage of CTVHR receiving 100% of the prescription dose in one IGABT plan without causing any associated complications. An ADS of ≥2.60 was the optimum cut-off value to decide whether to perform HGI. In conclusion, HGI is a useful procedure for improving target dose distribution while reducing D2.0 cm3 in the bladder in a single IGABT plan. The ADS can serve as a useful indicator for the implementation of HGI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidBrachytherapyUterine Cervical NeoplasmsRadiotherapy DosageGelsHumansFemaleMiddle AgedAgedRadiotherapy, Image-GuidedInjectionsAdultOrgans at RiskDose-Response Relationship, RadiationRadiotherapy Planning, Computer-AssistedTime FactorsRetrospective Studies

Stichwörter der Autor:innen

adjusted dose scorecervical cancerhyaluronate gel injectionimage-guided adaptive brachytherapyrectovaginal septumvesicovaginal septum

Substanzen

Hyaluronic AcidGels

Autor:innen und Institutionen

  • Department of Radiology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan.
  • Biostatistics Center, Kurume University, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan.
  • Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan.
  • Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

Zitieren

APA

Miyata, Y., Ogo, E., Murotani, K., Tsuda, N., Suzuki, G., Tsuji, C., Akeda, R., Muraki, K., Hattori, C., & Abe, T. (2024). Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the ‘adjusted dose score’. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrae031

Vancouver

Miyata Y, Ogo E, Murotani K, Tsuda N, Suzuki G, Tsuji C, et al. Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the ‘adjusted dose score’. Journal of Radiation Research. 2024. doi:10.1093/jrr/rrae031

BibTeX
@article{Miyata2024,
  author = {Miyata, Yusaku and Ogo, Etsuyo and Murotani, Kenta and Tsuda, Naotake and Suzuki, Gen and Tsuji, Chiyoko and Akeda, Ryosuke and Muraki, Koichiro and Hattori, Chikayuki and Abe, Toshi},
  title = {Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the ‘adjusted dose score’},
  journal = {Journal of Radiation Research},
  year = {2024},
  doi = {10.1093/jrr/rrae031}
}
Kostenlos starten →